Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director...

25
Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical, Inc.

Transcript of Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director...

Page 1: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Medical Device Development

Robert Hitchcock, Ph.D.

Director of Engineering & Technology Development

Sorenson Medical, Inc.

Page 2: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

What is a Medical Device?

1. recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them,

2. intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or

3. intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of it's primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes.

an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is:

Page 3: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Medical Device Industry

• Global market for medical devices exceeds $200B

• US market ~ 42% of WW market

• US innovation drives the market (more US producers than

rest of world combined)

• However.. it is increasingly difficult to commercialize

• Consumer v. agency regulation

• Increasing control improves safety and effectiveness at the

expense of commercial progress

• Overseas manufacturing and product launch

Page 4: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Page 5: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

• Picture of medical devices

Page 6: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Medical Device Regulation

• 1976 Medical device amendments to the FD&CA

• 1978 GMP

• 1987 – 1989 Process validation, design control

• 1990 SMDA – 44% of recalls due to faulty design

• 1996 QSR – harmonization, FDA, MDD, ISO

Page 7: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

The Big Picture - 21 CFR part 820 Quality System Regulation

Subpart A – General Provisions820.1 Scope820.3 Definitions820.5 Quality System

Subpart B – Quality System Requirements820.20 Management Responsibility820.22 Quality audit820.25 Personnel

Subpart C – Design controls820.30 Design controls

Subpart D – Document controls820.40 Document controls

Subpart E – Purchasing controls820.50 Purchasing controls

Subpart F – Identification and traceability820.60 Identification820.65 Traceability

Subpart G – Production and process controls820.70 Production and process controls820.72 Inspection, measuring and test equipment820.75 Process validation

Subpart H – Acceptance activities820.80 Receiving, in-process and finished device accept.820.86 Acceptance status

Subpart I – Nonconforming product820.90 Nonconforming product

Subpart J – Corrective and preventative action820.100 Corrective and preventative action

Subpart K – Labeling and packaging control820.120 Device labeling820.130 Device packaging

Subpart L – Handling, storage, distribution and installation820.140 Handling820.150 Storage820.160 Distribution820.170 Installation

Subpart M – Records820.180 General requirements820.181 Device master record820.184 Device history record820.186 Quality system record820.198 Complaint files

Subpart N – Servicing820.200 Servicing

Subpart O – Statistical techniques820.250 Statistical techniques

Page 8: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Control

• Design & Development Planning• Design input• Design output• Design review• Design verification• Design validation• Design transfer• Design changes• Design history file

Page 9: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

ManagementAssigns Project

and Project Manager

Design andDevelopment Plan

User Needs

Stated inuser terms

Marketing Requirements

measurable customer needs

Risk Analysis

Design Review

Design Review

Product Specifications

Design Review

Prototype Design

Design Verification

Protocols and accceptance

criteria

TraceabilityAnalysis

TraceabilityAnalysis

TraceabilityAnalysis

TraceabilityAnalysis

Post MarketSurveillance

Design Review

ManufacturingTransfer

Design Review

DesignValidation

Finalize Documentation

TraceabilityAnalysis

CO

NC

EP

TU

AL

PH

AS

E

SP

EC

IFIC

AT

ION

PH

AS

EP

RO

TO

TY

PE

P

HA

SE

FIN

AL D

ES

IGN

P

HA

SE

TR

AN

SF

ER

P

HA

SE

SMI Product Design & Development

Page 10: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Three Key Elements

1. Design Input

2. Risk Analysis

3. Design Output

Page 11: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Input

• User Needs

– what & why stated in user terms

• Marketing Requirements

– measurable, engineering terms

Page 12: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Input – User Needs

Over the Needle Catheter• Infuse fluids into subcutaneous tissue

• Sharp enough to penetrate skin easily

• Simple to remove needle from catheter

Page 13: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Input – Marketing Requirements

Over the Needle Catheter• WFI infused at 100 ml/hr, backpressure not to exceed 10 psi

• Max insertion force through 5 mil latex = 3N

• Max force to remove needle = 1N

Page 14: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Concept

Page 15: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Risk Analysis

• Failure mode• Potential effects• Severity

– 1 to 10 (negligible to potential for multiple deaths)

• Potential causes• Likelihood

– 1 to 10 (< 1 in 500,000 to > 1 in 2)

• Risk– Likelihood / severity matrix

• Mitigation

Page 16: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 17: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 18: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 19: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 20: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 21: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 22: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output - Specifications

Page 23: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output – Prototypes

Page 24: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

Design Output – Testing & Data

Verification

Validation

Page 25: Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Sorenson Medical, West Jordan, Utah USA

The Big Picture - 21 CFR part 820 Quality System Regulation

Subpart A – General Provisions820.1 Scope820.3 Definitions820.5 Quality System

Subpart B – Quality System Requirements820.20 Management Responsibility820.22 Quality audit820.25 Personnel

Subpart C – Design controls820.30 Design controls

Subpart D – Document controls820.40 Document controls

Subpart E – Purchasing controls820.50 Purchasing controls

Subpart F – Identification and traceability820.60 Identification820.65 Traceability

Subpart G – Production and process controls820.70 Production and process controls820.72 Inspection, measuring and test equipment820.75 Process validation

Subpart H – Acceptance activities820.80 Receiving, in-process and finished device accept.820.86 Acceptance status

Subpart I – Nonconforming product820.90 Nonconforming product

Subpart J – Corrective and preventative action820.100 Corrective and preventative action

Subpart K – Labeling and packaging control820.120 Device labeling820.130 Device packaging

Subpart L – Handling, storage, distribution and installation820.140 Handling820.150 Storage820.160 Distribution820.170 Installation

Subpart M – Records820.180 General requirements820.181 Device master record820.184 Device history record820.186 Quality system record820.198 Complaint files

Subpart N – Servicing820.200 Servicing

Subpart O – Statistical techniques820.250 Statistical techniques